Establishment of Optimal Transfusion Threshold After Major Orthopedic Surgery

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Anemia
Arthroplasty
Replacement
Hip

Treatments

Other: Allowed drop in hemoglobin to 4.5-5.5 mmol/L
Other: Allowed drop in hemoglobin to level between 5.6-6.5 mmol/L

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00906295
H-D-2009-024

Details and patient eligibility

About

The purpose of this study is to determine whether a higher threshold for transfusion with red blood cells improves the postoperative ambulation.

Enrollment

67 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Patients undergoing replacement of hip arthroplasty
  • Be legally competent
  • Read and understand Danish

Exclusion criteria

  • Present malignant disease
  • Known heart disease with functionality equivalent to NYHA II or CCS II or worse

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

67 participants in 2 patient groups

Allowed drop in hemoglobin to 4.5-5.5 mmol/L
Active Comparator group
Description:
Transfusion with red blood cells to level between 4.5-5.5 mmol/L
Treatment:
Other: Allowed drop in hemoglobin to 4.5-5.5 mmol/L
Allowed drop in hemoglobin to 5.6-6.5 mmol/L
Experimental group
Description:
Transfusion with red blood cells to level between 5.6-6.5 mmol/L
Treatment:
Other: Allowed drop in hemoglobin to level between 5.6-6.5 mmol/L

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems